Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 study.

Cançado, Rodolfo

Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 study. [electronic resource] - European journal of haematology Dec 2015 - 545-50 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article

1600-0609

10.1111/ejh.12530 doi


Adult
Aged
Benzoates--administration & dosage
Biomarkers
Deferasirox
Erythrocyte Indices
Female
Hemochromatosis--complications
Hemochromatosis Protein
Histocompatibility Antigens Class I--genetics
Humans
Iron Chelating Agents--administration & dosage
Iron Overload--diagnosis
Male
Membrane Proteins--genetics
Middle Aged
Mutation
Time Factors
Treatment Outcome
Triazoles--administration & dosage